Syqe Medical is a pharma-tech company that develops a precision inhalation platform designed to deliver central nervous system (CNS) drugs with pharmaceutical-grade accuracy. The company's technology features micro-dosing capabilities, consistent absorption technologies, and cloud-connected adherence tracking to optimize treatments for conditions such as diabetic peripheral neuropathic pain, PTSD, and insomnia.
Subscribe to see Syqe Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Syqe Medical is a medical devices company headquartered in Israel. It has raised at least $70M across the 2 funding rounds on record. Its most recent funding round, Undisclosed stage, raised $50M in December 2018.
At least $70M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Undisclosed stage | $50M | 3 named | |
| — | $20M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.